###begin article-title 0
Combined Effects of Thrombosis Pathway Gene Variants Predict Cardiovascular Events
###end article-title 0
###begin p 1
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(F5),</italic>
###xml 343 351 343 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(ICAM1),</italic>
###xml 362 369 362 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(PROC),</italic>
###xml 389 395 389 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(THBD)</italic>
###xml 614 615 614 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 640 641 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1221 1233 1221 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5 rs7542281</italic>
###xml 1236 1251 1236 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THBD rs1042580,</italic>
###xml 1279 1281 1279 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 1331 1346 1331 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PROC rs1041296,</italic>
###xml 1373 1388 1373 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM1 rs5030341</italic>
###xml 1392 1405 1392 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5 rs2269648,</italic>
###xml 1464 1479 1464 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PROC rs1401296,</italic>
###xml 1498 1500 1498 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 588 600 <span type="species:ncbi:9606">participants</span>
###xml 1195 1200 <span type="species:ncbi:9606">women</span>
###xml 1326 1329 <span type="species:ncbi:9606">men</span>
The genetic background of complex diseases is proposed to consist of several low-penetrance risk loci. Addressing this complexity likely requires both large sample size and simultaneous analysis of different predisposing variants. We investigated the role of four thrombosis genes: coagulation factor V (F5), intercellular adhesion molecule 1 (ICAM1), protein C (PROC), and thrombomodulin (THBD) in cardiovascular diseases. Single allelic gene variants and their pair-wise combinations were analyzed in two independently sampled population cohorts from Finland. From among 14,140 FINRISK participants (FINRISK-92, n = 5,999 and FINRISK-97, n = 8,141), we selected for genotyping a sample of 2,222, including 528 incident cardiovascular disease (CVD) cases and random subcohorts totaling 786. To cover all known common haplotypes (>10%), 54 single nucleotide polymorphisms (SNPs) were genotyped. Classification-tree analysis identified 11 SNPs that were further analyzed in Cox's proportional hazard model as single variants and pair-wise combinations. Multiple testing was controlled by use of two independent cohorts and with false-discovery rate. Several CVD risk variants were identified: In women, the combination of F5 rs7542281 x THBD rs1042580, together with three single F5 SNPs, was associated with CVD events. Among men, PROC rs1041296, when combined with either ICAM1 rs5030341 or F5 rs2269648, was associated with total mortality. As a single variant, PROC rs1401296, together with the F5 Leiden mutation, was associated with ischemic stroke events. Our strategy to combine the classification-tree analysis with more traditional genetic models was successful in identifying SNPs-acting either in combination or as single variants-predisposing to CVD, and produced consistent results in two independent cohorts. These results suggest that variants in these four thrombosis genes contribute to arterial cardiovascular events at population level.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
The genetic background of cardiovascular diseases is still largely unknown. As in other complex diseases, the genetic risk is thought to consist of several genetic variants and their possible interactions. Elucidation of the genetic component of any complex trait most likely requires simultaneous examination of various genes in large and well-characterized study samples. Our study explores the role in cardiovascular disease of four thrombosis genes: coagulation factor V, intercellular adhesion molecule 1, protein C, and thrombomodulin. These genes form a physiological pathway that is part of the coagulation cascade. Their defects, such as the Leiden mutation in factor V gene, predispose to venous thrombosis, making them tempting candidates for involvement with cardiovascular events. Given the interactions of these genes at the molecular level, a logical way to explore their genetic effects is simultanous rather than gene-specific analysis of all the four genes, aiming to illustrate their possible interplay. The study setting combines classification trees with classic genetic analyses and covers all known common variants of the genes. The results imply that the variants in these four genes contribute to disease risk either alone or in various allelic combinations.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b001">1</xref>
###xml 570 571 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b005">5</xref>
The genetic basis of complex diseases like coronary heart disease and ischemic stroke probably consists of several predisposing risk factors that can interact with environmental factors to produce the disease phenotype. To address such polygenic structure is a challenge likely requiring simultaneous analysis of several risk factors, including genetic variants, in large study samples rich in phenotypes. Gene-gene and gene-environment interaction studies have recently attempted to answer this challenge by analyzing the interacting relations of putative risk loci [1-5]. The majority of these studies, however, use two to three genetic markers, thus failing to address the physiological entities or the underlying complex genetic profiles.
###end p 6
###begin p 7
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b006">6</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b007">7</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b008">8</xref>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b009">9</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b010">10</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b011">11</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b012">12</xref>
###xml 815 817 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b013">13</xref>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b014">14</xref>
###xml 831 835 831 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THBD</italic>
###xml 903 905 903 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b015">15</xref>
###xml 436 444 <span type="species:ncbi:9606">patients</span>
In a physiological clotting cascade, binding of thrombin to its receptor, thrombomodulin (THBD), activates protein C (PROC). Activated protein C cleaves coagulation factor V (F5) [6], leading to fibrinolysis. Genetic variation in the cascade genes predisposes to increased clotting, the best known example being activated protein C resistance caused by the factor V Leiden mutation [7]. Several case reports describe PROC deficiency in patients with arterial thrombosis [8,9]. Activated protein C may also play a neuroprotective role in ischemic stroke [10,11]. THBD and intercellular adhesion molecule 1 (ICAM1) are markers for endothelial activation and damage [12]. Low concentrations of soluble THBD, especially when present along with elevated soluble ICAM1, predispose to cardiovascular disease (CVD) events [13,14]. Whether THBD gene variants act as independent CVD risk factors remains unclear [15].
###end p 7
###begin p 8
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b016">16</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b019">19</xref>
###xml 638 653 638 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5, ICAM1, PROC</italic>
###xml 659 663 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THBD</italic>
Studies on these four genes have mainly concentrated on a few, often rare, functional polymorphisms within the individual genes [16-19]. We hypothesize that analyzing allelic variants of several genes encoding components of the same physiological cascade will prove to be a more powerful approach to shedding light on CVD risk mechanisms than are studies on single candidates. Analyses comprising several genes belonging to the same pathway may reveal cumulative allelic effects. When acting together, these gene variants may affect the disease risk more profoundly than do the single predisposing variants. We covered common variants of F5, ICAM1, PROC, and THBD genes and assessed their role in CVD in two prospective and independently sampled population cohorts of Finns. To address the single gene variants and their interplay in cardiovascular traits, we chose a two-step strategy. We first aimed to identify the variants contributing most to the CVD risk in our study sample using classification-trees. Second, based on these analyses, we studied a subset of the most important SNPs by classical genetic analyses, first as independent markers and then as pair-wise combinations as deviation from the multiplicative model of genetic interaction. Our study identified several variants predisposing to CVD as single or cooperating markers.
###end p 8
###begin title 9
Materials and Methods
###end title 9
###begin title 10
Study Samples
###end title 10
###begin p 11
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 445 446 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 610 611 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1712 1713 1712 1713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1732 1733 1732 1733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1820 1821 1820 1821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1849 1850 1849 1850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1933 1940 1933 1940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030120-t001">Table 1</xref>
###xml 2286 2288 2286 2288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b015">15</xref>
###xml 2289 2291 2289 2291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b020">20</xref>
###xml 297 309 <span type="species:ncbi:9606">participants</span>
We utilized two large, independently sampled, and prospectively followed population cohorts from Finland, FINRISK-92 (n = 5,999, follow-up 1992-2001) and FINRISK-97 (n = 8,141, follow-up 1997-2003). Subjects for genotyping were selected according to a case-cohort design from among 14,140 FINRISK participants. As cases in this study, we consider those with an incident coronary event (coronary heart disease [CHD], n = 401) or ischemic stroke (n = 149) during follow-up and did not have acute coronary events or strokes before the baseline examination, and everyone deceased from any reason during follow-up (n = 610). In addition, individuals having experienced cardiovascular events at baseline were genotyped, but baseline CVD was not utilized as an endpoint in this study. International Classification of Diseases (ICD) -9 and -10 codes for fatal coronary events were 410-414 and 798, and I20-I25, I46, R96, R98, R99, and for nonfatal coronary events 410-411 (ICD-9) and I20.0 and I21-I22 (ICD-10). For fatal and nonfatal ischemic strokes, ICD-9 codes 433 (excluding 4330X, 4331X, and 4339X of the Finnish modification of ICD-9), 434 (excluding 4349X), and ICD-10 code I63 were used. The ICD-10 revision has been used in Finland since January 1996. We will denote the combination of coronary event and ischemic stroke endpoints by CVD. Because 21 individuals had both an incident coronary event and an incident ischemic stroke, the total number of individuals having incident CVD events was 528. Of the 610 deceased, 138 also had an incident CVD event. Random subcohorts, selected with age-dependent probabilities, were drawn from the original cohorts to represent the general study populations (FINRISK-92 n = 400, FINRISK-97 n = 386). Thus, the subcohorts also included individuals having CVD events at baseline (n = 88) or during follow-up (n = 72). This selection yielded a study sample of 2,222 individuals for genotyping (Table 1). Information on the traditional CVD risk factors (serum cholesterol, triglyceride (TG), and C-reactive protein (CRP) levels, blood pressure, anthropomorphic measures, smoking, medication, disease, and family history) as well as whole blood samples for DNA were collected at baseline. The study cohorts have been described in detail previously [15,20] and at . The Ethics Committee of the National Public Health Institute of Finland approved the study.
###end p 11
###begin p 12
Characteristics of the Study Cohorts: Number of Cardiovascular Events
###end p 12
###begin title 13
Genotyping Strategy
###end title 13
###begin p 14
###xml 150 152 150 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM1</italic>
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PROC</italic>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THBD</italic>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b015">15</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b021">21</xref>
###xml 313 315 313 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 332 340 332 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(rs6025)</italic>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b022">22</xref>
###xml 510 511 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 511 512 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 986 995 986 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rs3216183</italic>
###xml 1276 1278 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b023">23</xref>
###xml 1321 1326 1315 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM1</italic>
###xml 1331 1339 1325 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r5030380</italic>
###xml 1416 1417 1410 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1472 1474 1466 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b024">24</xref>
###xml 1807 1809 1801 1803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b025">25</xref>
###xml 1612 1617 <span type="species:ncbi:9606">child</span>
To cover all known common (frequency >10%) variants in the four thrombosis genes, 54 single nucleotide polymorphisms (SNPs) were selected: 24 SNPs in F5, nine in ICAM1, seven in PROC, and 14 in THBD [15]. This selection was based on haplotype information in the SeattleSNPs variation discovery resource [21]. The F5 Leiden mutation (rs6025) was included based on the literature. Haplotype structures in the four genes were analyzed with Haploview3.2 [22]. For any two SNPs in tight linkage disequilibrium (LD, r2 > 0.8) with each other, only one was included in further analyses. Because SNP selection was based on haplotype information, haplotype analyses were excluded. Baseline CVD cases were utilized in LD calculations, but had to be excluded from Cox's proportional hazard model due to the unknown time of the event measured (before the study began). Thus, the baseline cases were excluded from all statistical analyses to achieve a similar study sample used in all the analyses. Rs3216183 was genotyped with TaqMan (Roche Molecular Systems, ) and the remaining 53 SNPs with Sequenom MassARRAY (Sequenom, ) with 10 ng of DNA and hME chemistry. Primer information and assay conditions are available from the authors upon request. DNA was extracted by standard protocols [23] from whole blood stored at -20 degreesC. ICAM1 SNP r5030380 was excluded due to technical difficulties. The samples with low DNA yield (n = 100) were whole-genome amplified before genotyping [24]. Before genotyping the FINRISK samples, the Mendelian inheritance of each SNP was checked in a Finnish sample of 60 mother, father, and child trios. Mendel check revealed no errors. The FINRISK genotypic sample included 2% open and 5% blinded duplicates. Genotyping was performed as part of the MORGAM and GenomEUtwin Projects () [25]. The genotyping error rate was <1/400 in blind duplicate comparisons. The genotyping success rate was 93% or higher for each SNP. Together, these quality-control -procedures suggested very high genotyping quality.
###end p 14
###begin title 15
Statistical Analyses
###end title 15
###begin p 16
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b026">26</xref>
Statistical analyses were performed in three stages: (1) with AnswerTree3.0 (SPSS, ) to discover possible co-appearance of allelic variants as risk definers and to select the most significant SNPs for further analyses, and (2) with SAS v8.2 for Windows (SAS, ) to estimate allele frequencies, to discover SNPs influencing the traditional CVD risk factors, and to estimate hazard ratios (HR) of the SNP alleles with Cox's proportional hazards model [26]. (3) Finally, to estimate whether the SNPs chosen at stage 1 were the informative ones required a separate sensitivity analysis. All SNPs were analyzed in Cox's proportional hazards, coding the SNPs as 1-0 assuming dominant inheritance.
###end p 16
###begin p 17
###xml 1284 1285 1282 1283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
AnswerTree is a classification-tree algorithm that attempts to find a variable and a cutpoint for the variable to split a dataset to best predict disease outcome. This split is called the root node. The algorithm is then applied to the resulting subgroups of the dataset accordingly, and the process is continued to form a tree. In our application of the algorithm, SNPs were coded as 0 (minor allele carriers) to 1 (major allele homozygotes) assuming dominant inheritance and analyzed together with the traditional risk factors, using incident CVD events as the endpoint. Of the possible algorithms we used exhaustive chi-squared automatic interaction detector (CHAID), which allows more than two sister nodes in a split if necessary and thus was thought to model the biological risk caused by the phenotypic risk factors, for example cholesterol values, better than a strictly bifurcated split, and moreover, it allows control of a number of steps in the tree: To keep the tree structure simple and to discover combinations of predisposing factors affecting relatively large groups of individuals, we set the minimum root node size at 20 and the minimum end node size at 10. Maximum branch level in the trees was limited to five. The significance of all splits was calculated as chi2
###end p 17
###begin p 18
###xml 676 684 676 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030120-t001">Tables 1</xref>
###xml 689 690 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030120-t002">2</xref>
###xml 407 410 <span type="species:ncbi:9606">men</span>
###xml 451 456 <span type="species:ncbi:9606">women</span>
###xml 654 657 <span type="species:ncbi:9606">men</span>
###xml 669 674 <span type="species:ncbi:9606">women</span>
###xml 789 792 <span type="species:ncbi:9606">men</span>
###xml 810 815 <span type="species:ncbi:9606">women</span>
To search for all well-supported splits and to reduce the extent to which the root node in the overall analysis may obscure other important splits we decided, instead of growing a single tree, to grow a forest of trees: a collection of classification trees achieved by bootstrap techniques using random subsamples and other criteria. In order to grow the forest, we took ten random subsamples of 60% of the men and ten random subsamples of 60% of the women of the combination of the FINRISK-92 and -97 cohorts. First, one tree was grown for each subsample to determine the significant splits. These 20 trees included altogether 50 significant splits for men and 45 for women (Tables 1 and 2). Using these significant splits from the 20 trees as root nodes we grew a forest of 50 trees for men and 45 trees for women still utilizing the subsample data. The SNPs present in >10% of the sex-specific trees were selected for further analysis. Because the data used in the classification-tree analysis originated from a single dataset, combining the two cohorts, no cross validation among the samples was performed.
###end p 18
###begin p 19
###xml 36 37 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 48 49 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Significant Splits (Sample-Specific p-Value, chi2) Seen in Classification-Trees Grown in AnswerTree3.0 with Ten Random Female Datasets, Each Containing 60% of the Original Data
###end p 19
###begin p 20
###xml 326 327 324 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1474 1476 1472 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 1395 1398 <span type="species:ncbi:9606">men</span>
###xml 1403 1408 <span type="species:ncbi:9606">women</span>
At stage 2, we first used the combined data set of FINRISK-92 and -97 cohorts to gain maximum power, but also both cohorts separately to assess the consistency of the findings. The allele distributions of the selected SNPs between the cases and the subcohort (excluding cases and baseline CVD) were compared with Pearson's chi2. The relation of each SNP to the common CVD risk factors (TG, total cholesterol [TC], HDL cholesterol [HDL], TC/HDL ratio, systolic and diastolic blood pressure, CRP, body mass index [BMI], and waist-to-hip ratio [WHR]) was analyzed separately for each risk factor with an age-, sex-, and cohort-adjusted general linear model. To achieve normality, HDL and CRP were log transformed. Hazard ratios for all selected SNPs and their pair-wise combinations (with interaction terms, as deviation from the multiplicative model of interaction) were calculated with Cox's proportional hazards model, with age at baseline, (sex), TC/HDL ratio, BMI, smoking, diabetes, hypertension, and CRP as covariates. Time from baseline served as the time parameter. The analysis was stratified by eastern and western Finland and additionally by cohort when combining the two datasets. Total mortality, incident coronary, incident ischemic stroke, and incident CVD (coronary and stroke events combined) events served as endpoints. We first performed sex-specific analyses and then combined men and women, under additive, dominant, and recessive inheritance models. The F5 Leiden mutation was analyzed only with the dominant model, due to low minor allele frequency. Multiple testing was addressed by performing all analyses in the two separate cohorts, as well as with false-discovery rate (FDR). FDR was calculated within sex- and endpoint-specific groups. SNP combinations were analyzed with interaction terms as deviation from the multiplicative model (i.e., interaction HR different from the product of the independent SNP HRs) in Cox's model adjusted for the same risk factors as with the single SNPs. With interaction terms, the recessive model of inheritance was selected for a SNP if it showed significant association in the single SNP analyses, otherwise the dominant model was used to gain power. Results showing a consistent association or similar trend in the two separate study cohorts or their combination or both, and having FDR <0.1 for their combination were considered as significant.
###end p 20
###begin title 21
Results
###end title 21
###begin p 22
###xml 325 332 325 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030120-t003">Table 3</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b015">15</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b020">20</xref>
In both cohorts and in both sexes incident CVD cases had higher total cholesterol and BMI and lower HDL cholesterol at baseline than did subcohort members free of CVD at the end of follow-up. The CVD cases also had a higher frequency of diabetes and hypertension and more often smoked than did the healthy subcohort members (Table 3). The baseline characteristics of the cases and the subcohorts have been described in detail [15,20].
###end p 22
###begin p 23
Characteristics (Mean [Standard Deviation] or %) of the Study Cohorts
###end p 23
###begin p 24
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b027">27</xref>
###xml 238 270 238 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3766103, rs2227245, rs6670678,</italic>
###xml 275 282 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs6029,</italic>
###xml 282 291 282 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030120-sg001">Figure S1</xref>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM1</italic>
###xml 308 320 308 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(rs5030352),</italic>
###xml 325 329 325 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PROC</italic>
###xml 334 346 334 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(rs2069921),</italic>
###xml 355 359 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THBD</italic>
###xml 364 376 364 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(rs1042579),</italic>
###xml 400 401 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 501 611 499 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(rs5030388, rs9332566, rs9332625, rs9332587, rs1046712, rs1800576, rs1800577, rs1800578, rs1800579, rs3176122,</italic>
###xml 616 626 614 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3176121)</italic>
###xml 679 687 677 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030120-st002">Table S2</xref>
###xml 744 745 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Based on analyses with Haploview3.2, the LD pattern of our study sample of Finns, a population isolate known to retain higher levels of LD [27], differed from that provided by Seattle SNPs, and we excluded from the analyses four F5 SNPs (rs3766103, rs2227245, rs6670678, and rs6029,Figure S1), one ICAM1 SNP (rs5030352), one PROC SNP (rs2069921), and one THBD SNP (rs1042579), all showing strong LD (r2 >/= 0.8) with another SNP. In addition, SNPs monomorphic in 370 Finnish individuals were excluded (rs5030388, rs9332566, rs9332625, rs9332587, rs1046712, rs1800576, rs1800577, rs1800578, rs1800579, rs3176122, and rs3176121). The genotype frequencies of the remaining 36 SNPs (Table S2) followed Hardy-Weinberg equilibrium in the subcohorts (p > 0.05).
###end p 24
###begin p 25
###xml 468 475 468 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030120-t002">Table 2</xref>
###xml 480 488 480 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030120-st001">Table S1</xref>
###xml 674 676 674 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 705 716 705 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THBD, PROC,</italic>
###xml 721 726 721 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM1</italic>
###xml 735 737 735 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 744 752 744 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs970741</italic>
###xml 795 796 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 796 797 796 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 811 820 811 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2420369</italic>
###xml 822 831 822 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030120-sg001">Figure S1</xref>
###xml 876 883 876 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030120-t004">Table 4</xref>
###xml 982 990 982 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030120-g001">Figure 1</xref>
###xml 1361 1369 1361 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030120-g001">Figure 1</xref>
###xml 1371 1378 1371 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030120-t002">Table 2</xref>
###xml 1380 1388 1380 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030120-st001">Table S1</xref>
###xml 543 546 <span type="species:ncbi:9606">men</span>
###xml 558 563 <span type="species:ncbi:9606">women</span>
We aimed to reduce the number of variants used in further analyses and to discover possible co-effects of single gene variants by classification-tree analyses. The 36 SNPs, together with the baseline phenotypic variables (smoking, TC, TG, HDL, BMI, WHR, systolic and diastolic blood pressure, diabetes status, and CRP), were analyzed with AnswerTree3.0 with incident CVD as an endpoint. We grew a forest of classification-trees using each of the significant splits of Table 2 and Table S1 as root nodes. From this 95-tree forest (50 trees for men and 45 for women), we selected all SNPs present in >10% of the trees for further analyses. This selection yielded 12 SNPs: six F5 SNPs and two SNPs each from THBD, PROC, and ICAM1. Of the F5 SNPs, rs970741 was excluded due to relatively strong LD (r2 = 0.42) with rs2420369 (Figure S1), further reducing the SNP selection to 11 (Table 4). The rationale for this exclusion was to avoid an LD-based bias when analyzing SNP combinations. Figure 1 gives an example of a single tree grown with a random female sample. The figure also demonstrates a general pattern observed: the best splits seen with all subsamples were traditional phenotypic risk factors such as cholesterol or BMI, and the SNPs played a role in the lower branches of the trees, i.e., in subgroups of individuals specified by the phenotypic factors (Figure 1, Table 2, Table S1).
###end p 25
###begin p 26
Minor Allele Frequencies of the SNPs Analyzed in Stage 2 of the Study
###end p 26
###begin title 27
Example of a Classification-Tree in a Random Female Subsample Consisting of 60% of the Original Data
###end title 27
###begin p 28
SNPs are analyzed as 0 (minor allele carriers) to 1 (major allele homozygotes), modeling dominant inheritance.
###end p 28
###begin p 29
###xml 172 187 172 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM1 rs5030341</italic>
###xml 357 369 357 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5 rs7542281</italic>
###xml 399 400 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Next, we analyzed genotype-phenotype relationships of the 11 selected SNPs under additive, dominant, and recessive models of inheritance. The male minor allele carriers of ICAM1 rs5030341 had significantly smaller waist-to-hip ratio (p=0.0077 for combined cohorts, data not shown) than did the non-carriers of this allele, and the CVD cases homozygotic for F5 rs7542281 had significantly lower BMI (p = 0.0018 for combined cohorts, unpublished data). These observations were consistent in both cohorts.
###end p 29
###begin p 30
###xml 600 608 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030120-t003">Tables 3</xref>
###xml 610 611 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030120-t005">5</xref>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030120-t006">6</xref>
###xml 634 636 634 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 642 651 642 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7542281</italic>
###xml 705 720 705 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THBD rs1042580,</italic>
###xml 807 819 807 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5 rs2420369</italic>
###xml 869 883 869 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PROC rs1401296</italic>
###xml 939 954 939 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM1 rs5030341</italic>
###xml 963 975 963 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5 rs2269648</italic>
###xml 977 992 977 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM1 rs5030347</italic>
###xml 627 632 <span type="species:ncbi:9606">women</span>
###xml 864 867 <span type="species:ncbi:9606">men</span>
Separate Cox's proportional hazard models were fitted for all selected 11 SNPs and their pair-wise combinations. Incident coronary, incident ischemic stroke, incident cardiovascular events, and total mortality served as endpoints. We considered only SNPs showing consistent association in the separate cohorts or their combination or both, and exceeding the FDR <10% limit for the combined cohorts as significant. With pair-wise SNP combinations, a notable deviation from the multiplicative interaction model was additionally required. The Cox's model revealed several significant CVD risk variants (Tables 3, 5, and 6). Among women, F5 SNPs rs7542281 was associated with incident CVD. When combined with THBD rs1042580, substantial deviation from multiplicative model of interaction was seen. In addition, F5 rs2420369 was associated with incident CVD events. In men, PROC rs1401296 was associated with total mortality when combined with ICAM1 rs5030341 or with F5 rs2269648. ICAM1 rs5030347 was associated with total mortality as a single variant.
###end p 30
###begin p 31
Association of Single SNPs with the Endpoints in Time-to-Event Analysis
###end p 31
###begin p 32
###xml 64 66 64 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 71 80 71 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7542281</italic>
###xml 183 195 183 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5 rs2269648</italic>
###xml 250 264 250 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PROC rs1401296</italic>
###xml 280 282 280 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 576 584 576 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030120-t005">Tables 5</xref>
###xml 589 590 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030120-t006">6</xref>
###xml 593 601 593 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030120-g002">Figure 2</xref>
###xml 172 177 <span type="species:ncbi:9606">women</span>
###xml 245 248 <span type="species:ncbi:9606">men</span>
In analysis of coronary events and ischemic strokes separately, F5 SNP rs7542281 showed an association with both coronary and ischemic stroke events as a single variant in women, and F5 rs2269648 was associated with incident ischemic stroke. In men, PROC rs1401296, together with F5 Leiden mutation, was associated with incident ischemic stroke. The wide confidence intervals seen when analyzing stroke events in females reflect the small number of female stroke cases. Several other SNPs showed a suggestive association with the endpoints, but failed the FDR <0.1 criterion (Tables 5 and 6). Figure 2 shows a schematic overview of the contribution of the gene variants analyzed here to CVD.
###end p 32
###begin p 33
Association of Pair-Wise SNP Combinations with the Endpoints in Time-to-Event Analysis
###end p 33
###begin title 34
Schematic Overview of the Interplay of Traditional Cardiovascular Risk Factors and Genetic Variants Contributing to Disease Risk in Our Study Sample
###end title 34
###begin p 35
###xml 369 370 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 670 679 670 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030120-st004">Tables S4</xref>
###xml 680 683 680 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030120-st016">S16</xref>
The importance of the SNPs excluded from further analyses was assessed by analysis of all the 36 SNPs with Cox's proportional hazards model, assuming dominant inheritance, using combined cohorts in all the data and then with separate sexes. These results strongly suggest that the two-stage approach was able to recognize all informative SNPs: the significant results (p < 0.05) seen in Cox's model were concentrated in those SNPs selected for stage 2. With all the other SNPs showing statistical significance for the combined cohorts, the results from the separate study cohorts showed either a discrepancy in the hazard ratio or only one of the cohorts gave a signal (Tables S4-S16).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
Our present study provides a fresh way to utilize different methods to analyze the impact of multiple genes on a phenotype. This two-step analysis strategy used classification-trees to select a subset of SNPs from a larger set of genome-wide haplotype tagging SNPs for further genetic analyses of allelic covariance and hazard ratios. The importance of the SNPs excluded from the further analyses was assessed with a separate sensitivity analysis. Even though all genetic variants, or combinations of them, were required to show consistent effects in both the independent cohorts to be considered significant, only functional studies and replications in other populations will validate the importance of these findings for CVD. This may prove a valuable approach in whole-genome association analyses, where the amount of genetic data is overwhelming.
###end p 37
###begin p 38
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b028">28</xref>
###xml 2019 2021 2019 2021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 2130 2132 2130 2132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b029">29</xref>
###xml 742 745 <span type="species:ncbi:9606">men</span>
###xml 750 755 <span type="species:ncbi:9606">women</span>
###xml 2095 2100 <span type="species:ncbi:9606">women</span>
Classification-trees structure data by searching first for the variable best explaining the determined endpoint and splitting the dataset into subgroups according to this variable. The search continues in the specified subgroups, which again split into smaller groups accordingly. Classification-trees are thus useful in organizing noisy datasets comprising multiple variables, and can be used to identify specific pathways determining an outcome or specific subgroups having similarities leading to this outcome. Gruenewald et al. [28] utilized classification-trees to identify risk markers for mortality in an elderly population, and determined several mortality-predictive pathways consisting of different combinations of markers, in both men and women. Their study highlights the multiplicity of solutions leading to the same outcome and illustrates how classification-trees can prove useful in structuring multiple variables in an organized manner. In our data, the classification-tree analysis itself failed to detect consistent gene-gene or gene-environment interaction patterns, but was useful in reducing the number of SNPs analyzed with other models. In our dataset, the forest of trees demonstrated that the influence of any tested SNP on cardiovascular events was evident only after first splitting a tree by one or more traditional risk factors, such as cholesterol level, BMI, or diabetes. This fits well the current understanding of the nature of the complex diseases: setting aside some rare, strictly familial cases of CVD, the vast majority of cardiovascular diseases are likely to be characterized by several low-predisposing genes and their possible interactions. In these cases, the traditional phenotypic risk factors play a stronger role, and genetic factors are more likely to lurk in the background. Classification-trees could therefore prove powerful also in determining subsets, "branches," of individuals among whom the genetic variants are especially evident risk factors. For example, the F5 Leiden mutation has been suggested to be associated with CVD among young women with an unhealthy lifestyle [29].
###end p 38
###begin p 39
Our study identified several thrombosis-related risk variants-both single SNPs and their pair-wise combinations-for coronary events, ischemic strokes, and total mortality, showing consistent association in two independently selected Finnish population cohorts. Thrombosis is a central step in the pathogenesis of myocardial infarction and ischemic stroke. The ruptured wall of a coronary plaque is covered with thrombosis leading either to local obstruction of circulation or emboli traveling in more peripheral arterial branches. Thus, variants in thrombosis genes are also biologically relevant risk factors for coronary and stroke events. Our observations on various allelic combinations from several genes associating with CVD events highlight the importance of wide-perspective studies concentrating on numerous genes and their allelic variants to explore the genetic background of any complex trait. One should proceed cautiously when drawing biological conclusions from statistical interaction models: the underlying biological processes are likely to be highly complex, and evidence of combined effects in a statistical sense fails to do justice to this complexity. Our results indicate, however, that SNP combinations may reveal risk variants that could remain unnoticed when one is concentrating purely on single SNPs; SNP combinations could therefore be one step forward in the study of complex traits. Here, the CVD-associated variants of the candidate genes, excluding the Leiden mutation, represent either intronic or intragenic SNPs, likely linked to other, functional variants contributing to the true disease predisposition.
###end p 39
###begin p 40
###xml 15 17 15 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b030">30</xref>
###xml 132 134 132 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b031">31</xref>
###xml 206 208 206 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b032">32</xref>
###xml 334 336 334 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5</italic>
###xml 546 550 546 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THBD</italic>
###xml 555 564 555 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs6048519</italic>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b031">31</xref>
###xml 770 774 770 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THBD</italic>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b015">15</xref>
###xml 872 876 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THBD</italic>
###xml 992 997 992 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM1</italic>
###xml 1002 1008 1002 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs5498</italic>
###xml 1051 1053 1051 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030120-b019">19</xref>
###xml 1101 1102 1101 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1102 1103 1102 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1121 1131 1121 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3093030,</italic>
###xml 265 273 <span type="species:ncbi:9606">children</span>
###xml 294 297 <span type="species:ncbi:9606">men</span>
###xml 438 443 <span type="species:ncbi:9606">women</span>
###xml 527 530 <span type="species:ncbi:9606">men</span>
###xml 1328 1340 <span type="species:ncbi:9606">participants</span>
Studies on the F5 Leiden mutation in arterial thrombosis have been controversial [30], but a recent meta-analysis suggests that the F5 Leiden mutation contributes significantly to coronary events [31]. The F5 Leiden mutation also associated with ischemic stroke in children [32]. In our study, men carrying the risk (minor) allele of F5 Leiden were at a 4.47-fold increased risk for ischemic stroke, and a suggestive finding emerged when women were included in the analysis. The Leiden mutation also contributed to CVD risk in men jointly with a THBD SNP rs6048519. Addressing potential interactions for rare allelic variants, or to analyze the real impact of the Leiden mutation, requires very large datasets [31]. Our earlier results implied that in our study cohorts THBD variants alone seemed to play no role in CVD [15], but our new data from this study suggest that THBD may contribute to CVD in combination with other risk factors. Podgoreanu and colleagues reported an association of ICAM1 SNP rs5498 with postoperative myocardial infarction [19]. This SNP was in our population in strong LD (r2 = 0.82) with SNP rs3093030, but with no association with CVD. The wide confidence intervals in the analyses of female stroke cases reflect the need for larger study cohorts. In the present study, the number of female stroke participants was especially limited.
###end p 40
###begin p 41
###xml 89 105 89 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5, ICAM1, PROC,</italic>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THBD</italic>
This is, to our knowledge, the first study to cover all known common allelic variants in F5, ICAM1, PROC, and THBD genes, analyzing them as a physiological "pathway" entity and assessing their relationship with the traditional CVD risk factors. Multiple testing is an emerging issue in all complex genetics studies comprising several markers. We adjusted the findings of the final analysis step for multiple testing using the FDR, although this does not adjust for the fact that the earlier selection of SNPs by use of classification-trees was done on the same dataset. We chose to use 10% as a limit in the FDR analyses, stating that with this limit, 90% of the findings are expected to be true positives, whereas 10% could still be false positives. In addtition, the sensitivity analysis suggested that the classification-tree approach was able to select the informative SNPs, excluding the less informative ones. The major strength of this study is to further minimize the possibility of false-positive findings by requiring consistency in the findings in two separate cohorts of the same population. However, these results still need replication in other independent studies and populations. The major limitation of this study is its cohort size; studies comprising several hundred cases in each category are needed to profoundly address gene-gene interactions, especially once these types of analyses are reaching genome-wide datasets of thousands of genes. Another limitation of the study sample is the lack of plasma concentrations of the hemostatic factors.
###end p 41
###begin p 42
In conclusion, combining data from several genes encoding components of the same biological pathway and analyzing the impact of genes together with other relevant risk factors may prove useful in regard to studying diseases with polygenic structures. Currently, sensible ways are called for to analyze the overwhelming information load produced by studies containing various genes and many variants. Our approach provides one example for selecting the informative variants from the background. Our results from the thrombosis cascade of four genes shed light on the interplay of these gene variants' roles in arterial thrombosis.
###end p 42
###begin title 43
Supporting Information
###end title 43
###begin title 44
###xml 32 33 32 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Linkage Disequilibrium Pattern (r2) and Haplotype Blocks of the Coagulation Factor V SNPs Genotyped
###end title 44
###begin p 45
(71 KB JPG)
###end p 45
###begin p 46
Click here for additional data file.
###end p 46
###begin title 47
###xml 36 37 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 48 49 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Significant Splits (Sample-Specific p-Value, chi2) Seen in Classification-Trees Grown in AnswerTree3.0 with Ten Random Male Datasets, Each Containing 60% of the Original Data
###end title 47
###begin p 48
SNPs were analyzed as 0 (minor allele carriers) to 1 (major allele homozygotes).
###end p 48
###begin p 49
(11 KB DOC)
###end p 49
###begin p 50
Click here for additional data file.
###end p 50
###begin title 51
Minor Allele Frequencies of All SNPs Analyzed
###end title 51
###begin p 52
(141 KB DOC)
###end p 52
###begin p 53
Click here for additional data file.
###end p 53
###begin title 54
###xml 83 91 83 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030120-st006">Table S6</xref>
Estimates for the SNPs Contributing to the Pair-Wise SNP Combinations Presented in Table S6
###end title 54
###begin p 55
(12 KB DOC)
###end p 55
###begin p 56
Click here for additional data file.
###end p 56
###begin title 57
Association of the SNPs Studied with Incident Coronary Events in Time-to-Event Analysis in Both Sexes
###end title 57
###begin p 58
Covariates: age at baseline, (sex, cohort), smoking, hypertension, TC/HDL, BMI, diabetes, and CRP). FINRISK-92 and FINRISK-97 cohorts combined for the analysis. Analysis performed according to dominant inheritance model; hazard ratios >1 show major allele as the risk allele.
###end p 58
###begin p 59
(12 KB DOC)
###end p 59
###begin p 60
Click here for additional data file.
###end p 60
###begin title 61
###xml 91 94 <span type="species:ncbi:9606">Men</span>
Association of the SNPs Studied with Incident Coronary Events in Time-to-Event Analysis in Men
###end title 61
###begin p 62
Covariates: age at baseline, (sex, cohort), smoking, hypertension, TC/HDL, BMI, diabetes, and CRP. FINRISK-92 and FINRISK-97 cohorts combined for the analysis. Analysis performed according to dominant inheritance model; hazard ratios >1 show major allele as the risk allele.
###end p 62
###begin p 63
(12 KB DOC)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin title 65
###xml 91 96 <span type="species:ncbi:9606">Women</span>
Association of the SNPs Studied with Incident Coronary Events in Time-to-Event Analysis in Women
###end title 65
###begin p 66
Covariates: age at baseline, (sex, cohort), smoking, hypertension, TC/HDL, BMI, diabetes, and CRP. FINRISK-92 and FINRISK-97 cohorts combined for the analysis. Analysis performed according to dominant inheritance model; hazard ratios >1 show major allele as the risk allele.
###end p 66
###begin p 67
(12 KB DOC)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin title 69
Association of the SNPs Studied with Incident Ischemic Stroke Events in Time-to-Event Analysis in Both Sexes
###end title 69
###begin p 70
Covariates: age at baseline, (sex, cohort), smoking, hypertension, TC/HDL, BMI, diabetes, and CRP. FINRISK-92 and FINRISK-97 cohorts combined for the analysis, which comprises both sexes. Analysis performed according to dominant inheritance model; hazard ratios >1 show major allele as the risk allele.
###end p 70
###begin p 71
(12 KB DOC)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin title 73
###xml 98 101 <span type="species:ncbi:9606">Men</span>
Association of the SNPs Studied with Incident Ischemic Stroke Events in Time-to-Event Analysis in Men
###end title 73
###begin p 74
Covariates: age at baseline, (sex, cohort), smoking, hypertension, TC/HDL, BMI, diabetes, and CRP. FINRISK-92 and FINRISK-97 cohorts combined for the analysis. Analysis performed according to dominant inheritance model; hazard ratios >1 show major allele as the risk allele.
###end p 74
###begin p 75
(12 KB DOC)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin title 77
###xml 98 103 <span type="species:ncbi:9606">Women</span>
Association of the SNPs Studied with Incident Ischemic Stroke Events in Time-to-Event Analysis in Women
###end title 77
###begin p 78
Covariates: age at baseline, (sex, cohort), smoking, hypertension, TC/HDL, BMI, diabetes, and CRP. FINRISK-92 and FINRISK-97 cohorts combined for the analysis. Analysis performed according to dominant inheritance model; hazard ratios >1 show major allele as the risk allele.
###end p 78
###begin p 79
(12 KB DOC)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin title 81
Association of the SNPs Studied with Incident Cardiovascular (Coronary or Ischemic stroke) Events in Time-to-Event Analysis in Both Sexes
###end title 81
###begin p 82
Covariates: age at baseline, (sex, cohort), smoking, hypertension, TC/HDL, BMI, diabetes, and CRP. FINRISK-92 and FINRISK-97 cohorts combined for the analysis. Analysis performed according to dominant inheritance model; hazard ratios >1 show major allele as the risk allele.
###end p 82
###begin p 83
(12 KB DOC)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin title 85
###xml 127 130 <span type="species:ncbi:9606">Men</span>
Association of the SNPs Studied with Incident Cardiovascular (Coronary or Ischemic Stroke) Events in Time-to-Event Analysis in Men
###end title 85
###begin p 86
Covariates: age at baseline, (sex, cohort), smoking, hypertension, TC/HDL, BMI, diabetes, and CRP. FINRISK-92 and FINRISK-97 cohorts combined for the analysis. Analysis performed according to dominant inheritance model; hazard ratios >1 show major allele as the risk allele.
###end p 86
###begin p 87
(12 KB DOC)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin title 89
###xml 127 132 <span type="species:ncbi:9606">Women</span>
Association of the SNPs Studied with Incident Cardiovascular (Coronary or Ischemic Stroke) Events in Time-to-Event Analysis in Women
###end title 89
###begin p 90
Covariates: age at baseline, (sex, cohort), smoking, hypertension, TC/HDL, BMI, diabetes, and CRP. FINRISK-92 and FINRISK-97 cohorts combined for the analysis. Analysis performed according to dominant inheritance model; hazard ratios >1 show major allele as the risk allele.
###end p 90
###begin p 91
(12 KB DOC)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin title 93
Association of the SNPs Studied with Total Mortality in Time-to-Event Analysis in Both Sexes
###end title 93
###begin p 94
Covariates: age at baseline, (sex, cohort), smoking, hypertension, TC/HDL, BMI, diabetes, and CRP). FINRISK-92 and FINRISK-97 cohorts combined for the analysis. Analysis performed according to dominant inheritance model; hazard ratios >1 show major allele as the risk allele.
###end p 94
###begin p 95
(12 KB DOC)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin title 97
###xml 127 130 <span type="species:ncbi:9606">Men</span>
Association of the SNPs Studied with Incident Cardiovascular (Coronary or Ischemic Stroke) Events in Time-to-Event Analysis in Men
###end title 97
###begin p 98
Covariates: age at baseline, (sex, cohort), smoking, hypertension, TC/HDL, BMI, diabetes, and CRP. FINRISK-92 and FINRISK-97 cohorts combined for the analysis. Analysis performed according to dominant inheritance model; hazard ratios >1 show major allele as the risk allele.
###end p 98
###begin p 99
(12 KB DOC)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin title 101
###xml 82 87 <span type="species:ncbi:9606">Women</span>
Association of the SNPs Studied with Total Mortality in Time-to-Event Analysis in Women
###end title 101
###begin p 102
Covariates: age at baseline, (sex, cohort), smoking, hypertension, TC/HDL, BMI, diabetes, and CRP). FINRISK-92 and FINRISK-97 cohorts combined for the analysis. Analysis performed according to dominant inheritance model; hazard ratios >1 show major allele as the risk allele.
###end p 102
###begin p 103
(12 KB DOC)
###end p 103
###begin p 104
Click here for additional data file.
###end p 104
###begin title 105
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
SNPs Not Chosen for Stage 2 Analyses Based on the Classification-Trees and Showing p-Values <0.05 in the Analysis for Combined Study Cohorts Analyzed in the Separate Cohorts FINRISK-92 and FINRISK-97
###end title 105
###begin p 106
(12 KB DOC)
###end p 106
###begin p 107
Click here for additional data file.
###end p 107
###begin title 108
Accession Numbers
###end title 108
###begin p 109
The National Center for Biotechnology Information LocusLink () GeneID numbers for the genes discussed in this paper are Coagulation factor V (F5), 2153; Intercellular adhesion molecule 1, 3383; Protein C, 5624; and Thrombomodulin, 7056.
###end p 109
###begin p 110
###xml 51 63 <span type="species:ncbi:9606">participants</span>
We wish to thank all the FINRISK-92 and FINRISK-97 participants, and the Euroclot study. Siv Knaappila, Anne Nyberg, and Minna Suvela are thanked for their excellent laboratory assistance, and Samuli Ripatti, Tero Hiekkalinna, and Jaana Wessman for statistical assistance. The MORGAM data center is thanked for its participation in the data management.
###end p 110
###begin title 111
Abbreviations
###end title 111
###begin p 112
body-mass index
###end p 112
###begin p 113
coronary heart disease
###end p 113
###begin p 114
confidence interval
###end p 114
###begin p 115
C-reactive protein
###end p 115
###begin p 116
cardiovascular diseases
###end p 116
###begin p 117
false-discovery rate
###end p 117
###begin p 118
coagulation factor V
###end p 118
###begin p 119
high-density lipoprotein
###end p 119
###begin p 120
hazard ratio
###end p 120
###begin p 121
intercellular adhesion molecule 1
###end p 121
###begin p 122
International Classification of Diseases
###end p 122
###begin p 123
linkage disequilibrium
###end p 123
###begin p 124
total cholesterol-high-density cholesterol
###end p 124
###begin p 125
protein C
###end p 125
###begin p 126
standard deviation
###end p 126
###begin p 127
single nucleotide polymorphism
###end p 127
###begin p 128
total cholesterol
###end p 128
###begin p 129
total cholesterol to high-density cholesterol ratio
###end p 129
###begin p 130
triglycerides
###end p 130
###begin p 131
thrombomodulin
###end p 131
###begin p 132
waist-to-hip ratio
###end p 132
###begin title 133
References
###end title 133
###begin article-title 134
Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism
###end article-title 134
###begin article-title 135
No evidence of association or interaction between the IL4RA, IL4, and IL13 genes in type 1 diabetes
###end article-title 135
###begin article-title 136
###xml 84 92 <span type="species:ncbi:9606">children</span>
Gene-gene interaction between PPAR gamma 2 and ADR beta 3 increases obesity risk in children and adolescents
###end article-title 136
###begin article-title 137
Combining information from common type 2 diabetes risk polymorphisms improves disease prediction
###end article-title 137
###begin article-title 138
Subsets of SNPs define rare genotype classes that predict ischemic heart disease
###end article-title 138
###begin article-title 139
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide
###end article-title 139
###begin article-title 140
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
###end article-title 140
###begin article-title 141
Protein C deficiency manifesting as an acute myocardial infarction and ischaemic stroke
###end article-title 141
###begin article-title 142
A young adult with coronary artery and jugular vein thrombosis: A case report of combined protein S and protein C deficiency
###end article-title 142
###begin article-title 143
###xml 91 97 <span type="species:ncbi:10090">murine</span>
Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke
###end article-title 143
###begin article-title 144
###xml 62 67 <span type="species:ncbi:9606">human</span>
Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective
###end article-title 144
###begin article-title 145
Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study
###end article-title 145
###begin article-title 146
Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: A case-cohort study
###end article-title 146
###begin article-title 147
Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease
###end article-title 147
###begin article-title 148
Thrombomodulin gene polymorphisms and haplotypes and the risk of cardiovascular events: A prospective follow-up study
###end article-title 148
###begin article-title 149
Inherited defects of coagulation Factor V: The thrombotic side
###end article-title 149
###begin article-title 150
Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease
###end article-title 150
###begin article-title 151
Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic risk
###end article-title 151
###begin article-title 152
Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery
###end article-title 152
###begin article-title 153
###xml 60 65 <span type="species:ncbi:9606">women</span>
Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies
###end article-title 153
###begin article-title 154
Haploview: Analysis and visualization of LD and haplotype maps
###end article-title 154
###begin article-title 155
Blot hybridisation analysis of genomic DNA
###end article-title 155
###begin article-title 156
Evaluating whole genome amplification via multiply-primed rolling circle amplification for SNP genotyping of samples with low DNA yield
###end article-title 156
###begin article-title 157
MORGAM (an international pooling of cardiovascular cohorts)
###end article-title 157
###begin article-title 158
Robust variance estimation for the case-cohort design
###end article-title 158
###begin article-title 159
Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies
###end article-title 159
###begin article-title 160
Combinations of biomarkers predictive of later life mortality
###end article-title 160
###begin article-title 161
###xml 105 110 <span type="species:ncbi:9606">women</span>
Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women
###end article-title 161
###begin article-title 162
Genetic determinants of arterial thrombosis
###end article-title 162
###begin article-title 163
Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls
###end article-title 163
###begin article-title 164
###xml 100 108 <span type="species:ncbi:9606">children</span>
Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children
###end article-title 164
###begin p 165
A previous version of this article appeared as an Early Online Release on June 7, 2007 (doi:).
###end p 165
###begin p 166
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 595 607 <span type="species:ncbi:9606">participants</span>
Author contributions. K. Auro was responsible for the SNP selection and the data analyses, and participated in the genotyping. M. Alanne was responsible for the sample management and participated in the genotyping and the data analyses. K. Kristiansson participated in the genotyping and the data analyses. K. Silander participated in the genotyping and the whole-genome amplification of the DNA. K. Kuulasmaa participated in the study design and the assessment of the quality of the phenotypic data and the data analyses. V. Salomaa participated in the study design, recruitment of the FINRISK participants, and assessment of the clinical diagnoses. L. Peltonen participated in the study design and the data analyses. M. Perola is the principal investigator and holds responsibility of the overall study design and the data analyses. All authors participated in writing the manuscript.
###end p 166
###begin p 167
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This study was funded by the Finnish Foundation for Cardiovascular Research, the Biomedicum Helsinki Foundation, Sigrid Juselius Foundation, Jenny and Antti Wihuri Foundation, Aarne Koskelo Foundation, the Research Foundation of Orion Corporation, the Center of Excellence of Disease Genetics by the Academy of Finland, the GenomEUtwin-project () under the European Commission "Quality of Life and Management of the Living Resources" of 5th Framework Programme (QLG2-CT-2002-01254) and National Institutes of Health/ National Heart, Lung, and Blood Institute (1R01HL70150-01A1).
###end p 167
###begin p 168
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 168

